SUMOylation and PML NBs formation

Progress in Biochemistry and Biophysics

Volumn 37, Issue 7, 2010, Pages 707-712

  Li, Qian ^a   Pan, Cong ^a   Lei, Ming ^a,b  

^a NORTHWEST A F UNIVERSITY   (China)

^b Key Laboratory for Molecular Biology of Agriculture   (China)

Author keywords

FRET; PML NBs; RNF4; SUMOylation

Indexed keywords

MAMMALIA;

EID: 77958472355     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00017     Document Type: Review

References (48)

1. Melnick A, Licht J D. Deconstructing a desease: RARa, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 1999, 93(10): 3167-3215 (Pubitemid 29220886)
2. Reineke E L, Kao H Y. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int J Biol Sci, 2009, 5(4): 366-376
3. Damme E V, Laukens K, Dang T H, et al. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci, 2010, 6(1): 51-67
4. Brand P, Lenser T, Peter Hemmerich. Assembly dynamics of PML nuclear bodies in living cells. PMC Biophysics, 2010, 3: 3
5. Dellaire G, Bazett-Jones D P. PML nuclear bodies: dynamic sensors of DNA damage and celluar stress. Bioessays, 2004, 26(9): 963-977 (Pubitemid 39273070)
6. Bernardi R, Pandolfi P P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol, 2007, 8(10): 1006-1016 (Pubitemid 350174636)
7. Blom N, Sicheritz-Pontén T, Gupta R, et al. Prediction of posttranslational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 2004, (4): 1633-1649
8. Reineke E L, Kao H Y. PML: An emerging tumor suppressor and a target with therapeutic potential. Cancer Ther, 2009, 7(A): 219-226
9. Muratani M, Gerlich D, Janicki S M, et al. Metabolic-energydependent movement of PML bodies within the mammalian cell nucleus. Nature Cell Biol, 2002, 4(2): 106-110
10. Eskiw C H, Dellaire G, Bazett-Jones D P. Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1 independent mechanism. Biol Chem, 2004, 279 (10): 9577-9585 (Pubitemid 38296026)
11. Eskiw C H, Dellaire G, Mymryk J, et al. Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. Cell Sci, 2003, 116(part21): 4455-4466
12. Nichol J N, Petruccelli L A, Miller W H. Expanding PML's functional repertoire through post-translational mechanisms. Frontiers in Bioscience, 2009, 14: 2293-2306
13. Kurki S, Latonen L, Laiho M. Cellular stress and DNA damage invoke temporally distinct Mdm2, P53, and PML complexes and damage-specific nuclear relocalization. Cell Sci, 2003, 116(part19): 3917-3925
14. Dellaire G, Ching R W, Dehghani H, et al. The number of PML nuclear bodies increases in early S phase by a fission mechanism. Cell Sci, 2006, 119(part6): 1026-1033
15. Dellaire G, Eskiw C H, Dehghani H, et al. Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. Cell Sci, 2006, 119(part6): 1034-1042
16. Dellaire G, Farrall R, Bickmore W A. The nuclear protein database (NPD): sub-nuclear localization and functional annotation of the nuclear proteome. Nucl Acids Res, 2003, 31(1): 328-330 (Pubitemid 36157283)
17. Zhong S, Müller S, Ronchetti S, et al. Roel of SUMO-1 modified PML in nuclear body formation. Blood, 2000, 95(9): 2748-2752
18. Rodriguez M S, Dargemont C, Hay R T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem, 2001, 276: 12654-12659
19. Hay R T. SUMO: a history of modification. Mol Cell, 2005, 18(1): 1-12
20. Cheng J, Bawa T, Leey P, et al. Role of desumoylation in the development if prostate cancer. Neoplasia, 2006, 8(8): 667-676
21. Morris J R, Boutell C, Keppler M, et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature, 2009, 462: 886-892
22. Dasso M. Emerging roles of the SUMO pathway in mitosis. Cell Division, 2008, 3: 5
23. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?. Genes Dev, 2004, 18: 2046-2059 (Pubitemid 39166622)
24. Rodriguez M S, Dargemont C, Hay R T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. Biol Chem, 2001, 276(16): 12654-12659
25. Fu C H, Ahmed K, Ding H S, et al. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene, 2005, 24(35): 5401-5413
26. Tatham M H, Jaffray E, Vaughan O A, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. Biol Chem, 2001, 276(38): 35368-35364
27. Martin S F, Hattersley N, Samuel I D W, et al. A fluorescenceresonance- energy-transfer- based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing. Anal Biochem, 2007, 363(1): 38-45
28. Bossis G, Chmielarska K, Gartner U. A fluorescence resonance energy transfer-based assay to study SUMO modification in solution. Methods Enzymol, 2005, 398: 20-32 (Pubitemid 41578871)
29. Mukhopadhyay D, Ayaydin F, Kolli N, et al. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J Cell Biol, 2006, 174(7): 939-949
30. Nacerddine K, Lehembre F, Bhaumik M, et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell, 2005, 9(6): 769-779
31. Best J L, Ganiatsas S, Agarwal S, et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell, 2002, 10(4): 843-855
32. Hecker C M, Rabiller M, Haglund K, et al. Specification of SUMO1- and SUMO2- interacting motifs. Biol Chem, 2006, 281(23): 16117-16127
33. Song J, Durrin L K, Wilkinson T A, et al: Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci USA, 2004, 101(40): 14373-14378
34. Shen T H, Lin H K, Scaglioni P P, et al: The mechanisms of PML-nuclear body formation. Mol Cell, 2006, 24(3): 331-339
35. Takahashi H, Hatakeyama S, Saitoh H, et al. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. Biol Chem, 2005, 280(7): 5611-5621
36. Matunis M J, Zhang X D, Ellis N A. SUMO: the glue that binds. Dev Cell, 2006, 11(5): 596-597
37. Zhu J, Chen Z, Lallemand-Breitenbach V, et al. How acute promyelocytic leukaemia revived arsenic. Nature Rev Cancer, 2002, 2(9): 705-713
38. Tatham M H, Geoffroy M C, Shen L, et al. RNF4 is a poly-SUMOspecific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Bio, 2008, 10(5): 538-547
39. Petrie K, Zelent A. Marked for death. Nature Cell Bio, 2008, 10(5): 507-509
40. Lanllemand-Breitenbach V, Jeanne M, Benhenda S, et al. Arsenic degrades PML or PML-RARa through a SUMO-triggered RNF4/ ubiquitin-mediated pathway. Nat Cell Bio, 2008, 10(5): 547-556
41. Häkli M, Karvonen U, Jänne O A, et al. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies. Exp Cell Res, 2005, 304(1): 224-233
42. Weisshaar S R, Keusekotten K, Krause A, et al. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Lett, 2008, 582(21-22): 3174-3178
43. Percherancier Y, Germain-Desprez D, Galisson F, et al. Role of SUMO in RNF4-mediated PML degradation: PML sumoylation and phospho-switch control of its SUMO Binding Domain dissected in living cells. Biol Chem, 2009, 284(24): 16595-16608
44. Kaganman I. FRETing for a more detailed interactsome. Nat Methods, 2007, 4(2): 112-113
45. Voss T C, Demarco I A, Day R N. Quantitative imaging of protein interactions in the cell nucleus. Biotechniques, 2005, 38(3): 413-424
46. Wiesmeijer K, Molenaar C, Bekeer I M L A, et al. Mobile foci of Sp 100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. Struct Biol, 2002, 140(1-3): 180-188
47. Jares-Erijman E A, Jovin T M. Imaging molecular interactions in living cells by FRET microscopy. Curr Opin Chem Biol, 2006, 10(5): 409-416 (Pubitemid 44375073)
48. Wallrabe H, Periasamy A. Imaging protein molecules using FRET and FLIM microscopy. Curr Opin Biotechnol, 2005, 16(1): 19-27 (Pubitemid 40249755)